Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Total Liabilities
Everything the company owes to creditors and other parties.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.35B USD | +9.3% | -0.9% | 64.0% | |
| Mar 2026 | $803.6M USD | +71.4% | +15.6% | 108.0% | |
| Mar 2026 | $25.03M USD | -1.8% | +23.9% | 15.4% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 7.86M SEK | — | — | 8.2% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | +9.3% | +15.6% | 39.7% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.